|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Comparative study of in process and finished product Quality control test for IP, BP, and USP For Tablet |
| Authors Name: | Vaishnavi Khanderao Suryawanshi , Kranti Ashok Suryawanshi , Sandesh Ragho Nikam , Dnyaneshwari Suresh Bacchav , Puja.B. Mairal |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_184202
|
| Published Paper Id: | IJNRD2211200 |
| Published In: | Volume 7 Issue 11, November-2022 |
| DOI: | |
| Abstract: | The present study deals with a brief summary of the evaluation of the quality requirements for finished products quality control and in-process products quality control. Tests with certain common dosage forms according to the Indian Pharmacopeia (IP), British Pharmacopeia (BP), & United States Pharmacopeia (USP).Total quality control relates to the ability to produce a quality products through a number of steps, involving an arrangement to minimize errors at every stage of the production process. To maintain that the finished product conforms to the compendial standards stated in the pharmacopoeias, in-process product testing is performed. The pharmaceutical company works to manufacture high-quality goods, which is achieved by permitting methods for completed product and in-process quality control .There is a significant difference because the final sample used for the finished product testing is actually an example of a significant batch. In the exchange for a value to be compliant with the standards, the pharmacopoeias have defined the prescribed range that the value may stand. The quality standards for pharmaceutical products are specified in various regulatory active ingredients toward the country. Except for a few properties, it was observed that the quality control tests are mostly equivalent. To ensure that the intermediates, packaging materials, and finished pharmaceutical tablets conform with approved specifications or standards for efficacy, safety, and elegance that ensure the consumer that the products Perform consistently and in a manner satisfactory, in-process quality control is a concept that is carried out before, after, and during production covering all steps, including the establishment of specifications, sampling, relevant testing, and analytical clearance. Quality control involves checking products for problems that make it easier for the manufacturer to hold back product releases or conduct potential research to produce optimum pharmaceutical tablets. before released into the market As the comparing pharmacopoeias, an attempt is made to convey the harmonized limitations so that the products should conform with the specification as given in the pharmacopoeias to ensure the quality of pharmaceutical dosage form. This study aims to compare various quality control methods evaluations of medication tablets in accordance with various pharmacopoeia standards. |
| Keywords: | Indian Pharmacopeia, British Pharmacopeia, United, States Pharmacopeia, Tablet Quality control Tests, Quality Control Tests. |
| Cite Article: | "Comparative study of in process and finished product Quality control test for IP, BP, and USP For Tablet", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.b869-b878, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211200.pdf |
| Downloads: | 000118747 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2211200 Registration ID: 184202 Published In: Volume 7 Issue 11, November-2022 DOI (Digital Object Identifier): Page No: b869-b878 Country: Nashik, Maharashtra , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2211200 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2211200 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn